HLA-B and mitochondrial DNA depletion syndrome 4a: The fourth most frequent pharmacogenetic marker was the HLA-B*57:01 allele (2.72%), which is involved in abacavir-induced hypersensitivity syndrome (AHS); 73% of the carriers were women and 27% were men.